Long-Term Care Pharmacy Acquisition Financing
A long-term care pharmacy acquisition is different from buying a neighborhood retail store. Instead of walk-in customers, a long-term care pharmacy typically serves skilled nursing facilities, assisted living communities, group homes and similar settings under service agreements. That model can produce steady volume, but it also concentrates risk in a small number of facility relationships.
This guide explains how lenders tend to look at long-term care pharmacy deals and what buyers should understand before making an offer. Licensing, billing and facility contracting rules vary by state and payer, and nothing here is legal, tax, billing or compliance advice.
How Long-Term Care Pharmacies Earn Revenue
Long-term care pharmacies usually dispense medications in specialized packaging, deliver to facilities on set schedules, provide after-hours coverage and support facility staff with medication administration records and consultant services. Revenue may come from Medicare prescription drug plans, Medicaid, commercial insurers, facilities themselves and private-pay residents.
Because so much depends on service, the pharmacy’s operations, delivery network and technology are part of what a buyer is paying for, not just the prescription volume.
Facility Contract Concentration: The Central Risk
The biggest question in most long-term care deals is how dependent the pharmacy is on a handful of facilities. If one large facility or one operator with several buildings accounts for a significant share of revenue, the loss of that relationship could change the economics of the business overnight.
Buyers and lenders will typically review:
- Revenue and prescription volume by facility and by operator
- Length and terms of each service agreement
- Termination rights, notice periods and any change-of-control provisions
- Whether agreements can be assigned to a buyer, and whether consent is required
- How long each facility has used the pharmacy and how satisfied it appears to be
- Whether facility operators are themselves being sold or consolidated
Facility agreements should not be assumed to transfer. Healthcare counsel should review assignment and consent language early, because the answer can affect deal structure, price and timing.
What Lenders Evaluate in a Long-Term Care Pharmacy Acquisition
Beyond concentration, lenders tend to focus on several areas.
Cash Flow Quality
Lenders generally want to see several years of documented cash flow that can support debt payments after a reasonable salary for the owner. They may adjust that cash flow if a major contract is up for renewal, if a facility has given notice or if reimbursement for a key payer is changing.
Receivables and Payment Timing
Long-term care pharmacies may bill facilities directly for certain residents, which creates receivables that need to be collected. Lenders may review receivables aging and collection history to understand how much cash is tied up and how reliable collections are.
Operations and Management
Delivery routes, drivers, packaging equipment, after-hours coverage and consultant pharmacists all have to keep running after closing. Lenders may want to know who manages each function and whether key staff are staying. A buyer with long-term care experience may be viewed more favorably than one moving from retail for the first time.
Licenses and Payer Enrollments
Pharmacy licenses, controlled substance registrations, Medicare and Medicaid enrollments and payer network contracts should not be assumed to transfer. Our article on pharmacy change of ownership explains how contracts and licenses are handled in a sale.
Structuring the Financing
Depending on the transaction, a buyer may consider SBA-backed loans, conventional practice loans or a combination with seller participation. SBA 7(a) loans can be used to help finance the purchase of an existing pharmacy and may include working capital, subject to program rules and lender approval. Eligibility and terms depend on the business, the buyer, the use of proceeds and lender review, and nothing here is a commitment to lend.
Because concentration risk is hard to eliminate, some buyers and sellers discuss tying part of the price to facility retention. Lenders and program rules may limit earnouts, and seller notes are typically subordinate to the primary lender. Our article on pharmacy acquisition earnouts explains how these terms interact with financing.
Plan for Transition Working Capital
Long-term care pharmacies often carry significant inventory and receivables. After closing, a buyer may need cash to fund inventory, payroll and delivery costs while payer enrollments are updated and facility billing resumes under new ownership.
Including adequate pharmacy working capital in the financing plan can give a new owner room to handle delays without straining relationships with wholesalers or facilities.
Due Diligence Priorities
A standard pharmacy due diligence checklist is a good starting point. For a long-term care pharmacy acquisition, buyers should also review:
- Every facility service agreement and any amendments
- Facility-level profitability, including delivery and staffing costs
- Packaging and dispensing equipment, including any leases
- Consultant pharmacist arrangements
- Audit history, which should be reviewed by qualified billing or compliance professionals
- Vehicle ownership, insurance and driver arrangements
Questions to Ask the Seller
Before signing a letter of intent, buyers may want to ask:
- Which facilities have been added or lost recently, and why?
- Has any facility asked for pricing changes or service changes?
- Who holds the relationship with each facility’s leadership?
- Will the seller help introduce the buyer and stay through a transition period?
Final Thoughts
A long-term care pharmacy acquisition can offer scale and steady volume, but its value depends on facility relationships that may not survive a sale without careful planning. Buyers who understand concentration, contract terms, receivables and operational demands before closing can structure a deal that a lender is more likely to support.
US Medical Funding helps pharmacists and pharmacy groups finance acquisitions of independent, specialty and long-term care pharmacies. Learn more about our pharmacy acquisition financing and our full range of pharmacy financing options.



